<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0048">
 <label>48</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Uckun</surname>
    <given-names>FM</given-names>
   </string-name>, 
   <string-name>
    <surname>Zheng</surname>
    <given-names>Y</given-names>
   </string-name>, 
   <string-name>
    <surname>Cetkovic-Cvrlje</surname>
    <given-names>M</given-names>
   </string-name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>In vivo pharmacokinetic features, toxicity profile, and chemosensitizing activity of alpha-cyano-beta-hydroxy-beta- methyl-N-(2,5-dibromophenyl)propenamide (LFM-A13), a novel antileukemic agent targeting Bruton’s tyrosine kinase</article-title>. 
  <source>Clin Cancer Res</source>
  <year>2002</year>;
  <volume>8</volume>:
  <fpage>1224</fpage>–
  <lpage>33</lpage>.
  <pub-id pub-id-type="pmid">12006542</pub-id>
 </mixed-citation>
</ref>
